# Knock Out Mice Model Market > Knockout Mice Model Market Research Report By Application (Oncology Research, Genetic Research, Pharmaceutical Research, Immunology Research), By Type (Constitutive Knockout Mice, Conditional Knockout Mice, Transgenic Mice), By Key End User (Academic Institutions, Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations), By Technology (CRISPR-Cas9, Homologous Recombination, Gene Targeting) and By Regional (North America, Europe, South America, Asia-Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 7.32% - **2024:** $ 2.74 Billion - **2025:** $ 2.94 Billion - **2035:** $ 5.97 Billion - **Key Players:** Jackson Laboratory (US), Charles River Laboratories (US), Taconic Biosciences (US), Horizon Discovery (GB), GenOway (FR), Crown Bioscience (US), InVivo Biosystems (US), The Jackson Laboratory (US) **Report ID:** MRFR/HC/30879-HCR · **Pages:** 128 · **Author:** Rahul Gotadki · **Last Updated:** May 15, 2026 **URL:** https://www.marketresearchfuture.com/reports/knock-out-mice-model-market-32678 --- ## Market Summary ## **Knockout Mice Model Market Overview** As per MRFR analysis, the Knock Out Mice Model Market Size was estimated at 2.74 (USD Billion) in 2024. The Knock Out Mice Model Market Industry is expected to grow from 2.94 (USD Billion) in 2025 to 5.56 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 7.32% during the forecast period (2025 - 2034). ### **Key Knockout Mice Model Market Trends Highlighted** The Global Knockout Mice Model Market is witnessing significant growth due to several key market drivers. Increased investment in biomedical research, driven by the demand for advanced therapeutic solutions, is propelling the use of knockout mice in studies related to genetic disorders, cancer, and cardiovascular diseases. The rise of personalized medicine is also fueling the need for precise animal models that can closely mimic human genetic conditions. Additionally, supportive government initiatives and funding for research and development activities further stimulate market growth. There are abundant opportunities to be explored in the knockout mice model market, primarily in areas that focus on innovation in genetic engineering technologies. As CRISPR and other gene-editing tools become more accessible, researchers are likely to adopt these advanced techniques to create custom models tailored to specific research needs, thus enhancing the scope of studies conducted. Collaboration between academia and industry can also lead to the development of novel knockout mouse models that address unmet medical needs, expanding their application in drug discovery and toxicology studies. Recent trends indicate a shift toward the use of high-throughput screening techniques and more sophisticated genetic manipulations that offer researchers greater efficiency and accuracy. The increasing integration of artificial intelligence and machine learning in research, including the analysis of knockout mice data, is also transforming the landscape. This convergence allows for an enhanced understanding of biological pathways, paving the way for new therapeutic discoveries. As the market evolves, ethical considerations and animal welfare regulations are becoming integral, driving the need for more comprehensive and humane research practices. Overall, the knockout mice model market is positioned for continued expansion, driven by technological advancements, heightened research initiatives, and an ever-growing focus on precision medicine. **Source: Primary Research, Secondary Research, MRFR Database and Analyst Review** ## **Knockout Mice Model Market Drivers** ### **Rising Demand for Customized Mouse Models** The Global Knockout Mice Model Market Industry is experiencing a significant surge in demand for customized and genetically modified mouse models. This increasing requirement arises from the need for more precise and relevant animal models in biological and biomedical research. Organizations are focused on creating animal models that closely mimic human diseases, which allows for an improved understanding of disease mechanisms and accelerated drug discovery processes. As researchers seek to develop therapies tailored to specific patient populations, they are turning towards knockout mice models for their ability to elucidate the role of specific genes in diseases. With advances in genetic engineering techniques, including CRISPR and other genome editing technologies, the creation of customized knockout mice has become more efficient and cost-effective. This shift towards precision medicine and targeted therapies is anticipated to drive substantial growth in the Global Knockout Mice Model Market, as researchers require these models to study complex diseases like cancer, cardiovascular diseases, and neurological disorders. Furthermore, as regulatory agencies emphasize the need for reliable preclinical data, the reliance on genetically modified mouse models is expected to increase. The capacity of knockout mice to mimic human conditions and respond to treatments in a manner reflective of human biology positions them as invaluable assets in the pharmaceutical and biotechnology sectors. Consequently, the customizability of knockout mice models tailored to specific genetic backgrounds enhances their appeal, ultimately supporting the expansion of the Global Knockout Mice Model Market. ### **Increasing Investment in Pharmaceutical Research and Development** The rising investments in pharmaceutical research and development are significantly bolstering the Global Knockout Mice Model Market Industry. With a growing focus on innovative drug development and the need for efficient testing methods, pharmaceutical companies are increasingly turning to knockout mice models as a foundational tool in their R processes. These models allow for the evaluation of therapeutic efficacy, safety, and mechanisms of action, leading to more successful clinical outcomes. The substantial funding being allocated by both public and private sectors for drug discovery further emphasizes the critical role of animal models in translating research into viable therapies. Consequently, this trend is set to propel the growth of the Global Knockout Mice Model Market as organizations seek to meet the demands of modern pharmaceutical research. ### **Advancements in Genetic Engineering Techniques** Technological advancements in genetic engineering techniques are a primary driver of growth in the Global Knockout Mice Model Market Industry. Innovations such as CRISPR-Cas9 and other genome editing tools have revolutionized the creation of knockout mice, making the process more precise, efficient, and less time-consuming. These advancements facilitate the generation of mouse models that can accurately represent specific genetic alterations, offering valuable insights into various diseases. The ability to manipulate genes with high specificity enhances the relevance of knockout models in research, prompting pharmaceutical companies and academic institutions to adopt these technologies. As a result, the ongoing evolution of genetic engineering capabilities directly influences the growth trajectory of the Global Knockout Mice Model Market, enabling researchers to explore new therapeutic avenues and enhance preclinical testing protocols. ## **Knockout Mice Model Market Segment Insights** ### **Knockout Mice Model Market Application Insights** The Application segment within the Global Knockout Mice Model Market is a pivotal aspect that highlights the diverse areas of research leveraging these models. As of 2023, the overall market is valued at 2.39 USD Billion, reflecting the growing reliance on knockout mice for biomedical research. The segment includes key applications such as Oncology Research, Genetic Research, Pharmaceutical Research, and Immunology Research, each playing a crucial role in advancing scientific knowledge and therapeutic developments. Oncology Research holds the largest share, valued at 0.95 USD Billion in 2023, and is projected to grow to 1.8 USD Billion by 2032, underscoring its significance in cancer research. The extensive use of knockout mice in this area aids in understanding tumor biology and developing targeted therapies. Genetic Research, valued at 0.65 USD Billion in 2023, is another significant area, expected to reach 1.2 USD Billion by the end of the forecast period. This application is critical for insights into genetic diseases and gene function, making it foundational for the development of gene editing technologies and personalized medicine. Pharmaceutical Research, at 0.59 USD Billion in 2023, is projected to grow to 1.1 USD Billion by 2032, highlighting its role in drug discovery and efficacy testing, where knockout models help in elucidating drug mechanisms and potential downstream effects. Lastly, Immunology Research, although the smallest segment valued at 0.2 USD Billion in 2023, is expected to double to 0.4 USD Billion by 2032. This application enables researchers to study immune responses and develop vaccines, making it essential for public health initiatives. The evident dominance of Oncology Research within the Global Knockout Mice Model Market reflects its critical importance in addressing one of the most challenging health issues worldwide, while Genetics and Pharmaceutical Research also play crucial roles in revolutionizing modern medicine. Various market trends indicate a growing investment in these areas, driven by advancements in technology and a greater focus on personalized treatments. Therefore, the Global Knockout Mice Model Market data reveals a dynamic landscape marked by significant growth opportunities and challenges, particularly in expanding the application of these models to further enhance research capabilities across multiple disciplines. **Source: Primary Research, Secondary Research, MRFR Database and Analyst Review** ### **Knockout Mice Model Market Type Insights** In 2023, the Global Knockout Mice Model Market was valued at 2.39 billion USD, reflecting a robust market focused on various types of knockout mice, including Constitutive, Conditional, and Transgenic Mice. Constitutive Knockout Mice, which have gene deletions that occur in all cells, often play a critical role in studying gene function across different tissues, aiding biomedical research substantially. Conditional Knockout Mice provide an advantage by allowing researchers to control when and where genes are inactivated, leading to more targeted studies, which have gained traction due to their precise applications in disease modeling. Transgenic Mice, designed to carry extra genes, significantly contribute to understanding gene expression and function, hence occupying a significant portion of the market share. These mouse types are increasingly used due to their essential roles in drug development, genetic research, and studying various diseases. The market growth is propelled by advancements in genetic engineering technologies and an increasing focus on personalized medicine, although challenges like ethical concerns and high production costs continue to impact accessibility. As the landscape for research methodologies evolves, the need for innovative knockout models will drive the Global Knockout Mice Model Market revenue further upwards. ### **Knockout Mice Model Market Key End User Insights** In 2023, the Global Knockout Mice Model Market was valued at approximately 2.39 billion USD and is experiencing significant traction due to its application across various key end users. Academic institutions are crucial players, utilizing knockout mice models extensively for genetic research and educational purposes. Biotechnology companies also contribute notably to the market, focusing on innovative therapies and drug development, which rely heavily on these models to understand gene functions. Pharmaceutical companies dominate this space, as they leverage knockout mice for preclinical studies to test drug efficacy and safety. Furthermore, contract research organizations play a vital role in offering services that streamline the research process for biotech and pharmaceutical companies. The increasing demand for personalized medicine and advancements in genetic engineering are driving the growth of these end-user segments, contributing to a robust market landscape. Challenges such as ethical considerations and regulatory hurdles persist, but the opportunities for innovation and research advancement remain promising, positioning the Global Knockout Mice Model Market for continued growth and engagement across key sectors. ### **Knockout Mice Model Market Technology Insights** The Technology segment of the Global Knockout Mice Model Market reflects substantial growth, with the overall market valued at 2.39 USD Billion in 2023. As science progresses, techniques such as CRISPR-Cas9 have gained prominence due to their efficiency and precision in gene editing, making them crucial for advancing genetic research. Homologous recombination also plays a significant role, providing established methodologies for targeted gene alteration in mice. Gene targeting remains foundational as it helps create specific mutations for studying various diseases, thus enabling significant discoveries in biomedical research. Together, these methodologies demonstrate the dynamic landscape of the Global Knockout Mice Model Market, showcasing the integration of innovative technologies that drive research and therapeutic developments. The market, driven by increasing demand for personalized medicine and genetic studies, faces challenges such as ethical considerations and regulatory hurdles, but opportunities in novel applications continue to emerge, fostering robust market growth. The importance of these technologies is underscored by their ability to enhance understanding of genetic functions and promote the development of advanced treatment strategies. ### **Knockout Mice Model Market Regional Insights** The Global Knockout Mice Model Market revenue is witnessing consistent growth across various regions, with North America taking a significant lead in market valuation. In 2023, North America was valued at 1.05 USD Billion and is projected to reach 2.1 USD Billion by 2032, demonstrating its majority holding in the market. Europe follows as another key player, registering a market value of 0.8 USD Billion in 2023 and advancing to 1.4 USD Billion by 2032, highlighting its important role in research and development. The APAC region, valued at 0.41 USD Billion in 2023, shows potential for growth, reaching 0.9 USD Billion by 2032, driven by increasing investments in biotechnology. South America and MEA represent smaller yet developing segments, with valuations of 0.07 USD Billion and 0.06 USD Billion in 2023, respectively, expected to grow modestly to 0.15 USD Billion each by 2032. The market faces challenges such as stringent regulations and high costs, but opportunities arise from improved research capabilities and technological advancements, enhancing overall market growth and Global Knockout Mice Model Market statistics. **Source: Primary Research, Secondary Research, MRFR Database and Analyst Review** ## **Knockout Mice Model Market Key Players and Competitive Insights:** The competitive landscape of the Global Knockout Mice Model Market is characterized by a diverse array of players, each contributing to the advancement of genetic research and pharmaceutical development through innovative approaches. This market has seen significant growth due to the increasing demand for personalized medicine and the rising prevalence of genetic disorders. As research institutions and pharmaceutical companies strive to overcome challenges in drug development and understanding complex diseases, the need for precise and reliable animal models becomes paramount. Knockout mice, which are genetically modified to lack specific genes, serve as critical tools in this endeavor. Thus, companies involved in the production and development of knockout mice are continuously enhancing their technologies, methodologies, and service offerings, creating a dynamic competitive environment that drives innovation and collaboration across the industry. genOway stands out in the Global Knockout Mice Model Market due to its strong focus on customized genetic models and its commitment to high-quality service. The company leverages advanced genetic engineering techniques to develop tailored knockout models that meet specific client requirements, thereby addressing unique research questions. This adaptability gives genOway a competitive advantage, as researchers are increasingly seeking models that closely mimic human diseases for more effective drug testing and therapeutic development. With a robust portfolio of knockout mice that are effectively validated for various applications, genOway enjoys a solid reputation among academic and biotech organizations. The company's emphasis on customer support, scientific expertise, and reliability further solidifies its market presence, allowing it to build long-term partnerships with clients in need of sophisticated genetic models. Charles River Laboratories holds a prominent position in the Global Knockout Mice Model Market, recognized for its comprehensive portfolio of research models and in-depth expertise in genetic engineering. The company has established a reputation for delivering high-quality knockout models that accelerate drug discovery and preclinical development. Charles River Laboratories distinguishes itself through its extensive breeding and production capabilities, ensuring a consistent supply of genetically modified mice that meet stringent quality standards. Furthermore, the company emphasizes innovation through ongoing investment in cutting-edge technology and research collaborations, enabling it to stay at the forefront of genetic research. The combination of a wide-ranging product offering and a focus on advancing genetic models makes Charles River Laboratories a key player in the knockout mice market, catering to diverse needs across the pharmaceutical and academic sectors. ### **Key Companies in the Knockout Mice Model Market Include** - genOway - Charles River Laboratories - Horizon Discovery - The Jackson Laboratory - Envigo - Biocytogen - Cure Genetics - Thermo Fisher Scientific - Crown Bioscience - Integrative Biology - Celerion - OncoOne - **[Jackson Laboratory](https://www.jax.org/orderform)** - Taconic Biosciences - PharmaCyte Biotech ## **Knockout Mice Model Market Industry Developments** In the Global Knockout Mice Model Market, significant recent developments have been noted, particularly among leading companies like genOway, Charles River Laboratories, and Horizon Discovery. These organizations have been increasingly focusing on expanding their product portfolios and enhancing their technological capabilities to meet growing research demands. The Jackson Laboratory and Envigo have also made strides in improving the genetic engineering techniques used for creating knockout mice, which contribute to advancements in biomedical research. Additionally, Biocytogen has gained attention for its innovative models catering to specific therapeutic areas. On the merger and acquisition front, notable transactions have involved key players such as Thermo Fisher Scientific and Crown Bioscience, with activities aimed at consolidating capabilities and expanding market reach. The financial health of companies involved in this market has been bolstered by a rising demand for genetic disease modeling, significantly impacting overall market growth. This evolution reflects a dynamic landscape where collaboration, technological innovation, and strategic partnerships are paramount for driving the success of knockout mice models in various research applications. ## **Knockout Mice Model Market Segmentation Insights** ### **Knockout Mice Model Market Application Outlook** - Oncology Research - Genetic Research - Pharmaceutical Research - [Immunology](../../../reports/immunology-market-30261) Research ### **Knockout Mice Model Market Type Outlook** - Constitutive Knockout Mice - Conditional Knockout Mice - Transgenic Mice ### **Knockout Mice Model Market Key End User Outlook** - Academic Institutions - Biotechnology Companies - Pharmaceutical Companies - Contract Research Organizations ### **Knockout Mice Model Market Technology Outlook** - CRISPR-Cas9 - Homologous Recombination - Gene Targeting ### **Knockout Mice Model Market Regional Outlook** - North America - Europe - South America - Asia-Pacific - Middle East and Africa ## Market Drivers ### Collaborative Research Initiatives The Knockout Mice Model Market benefits from collaborative research initiatives among academic institutions, pharmaceutical companies, and biotechnology firms. These partnerships often focus on the development of novel therapeutic strategies and the validation of new drug targets using knockout mice. Such collaborations enhance resource sharing and knowledge exchange, which can lead to more efficient research outcomes. As of 2025, numerous initiatives are underway that leverage knockout mice to study complex diseases, including cancer and neurodegenerative disorders. The increasing number of joint research projects is likely to propel the demand for knockout mice models, as they provide a reliable platform for testing hypotheses and validating findings across various research domains. ### Advancements in Genetic Engineering The Knockout Mice Model Market is experiencing a surge due to advancements in genetic engineering techniques. Innovations such as CRISPR-Cas9 and TALENs have revolutionized the ability to create precise genetic modifications in mice. This precision allows researchers to develop models that closely mimic human diseases, thereby enhancing the relevance of preclinical studies. As of 2025, the market for genetic engineering tools is projected to reach substantial figures, indicating a robust growth trajectory. The ability to generate knockout mice with specific gene deletions facilitates the exploration of gene functions and disease mechanisms, which is crucial for drug discovery and development. Consequently, the demand for knockout mice models is likely to increase as researchers seek to leverage these advanced techniques to accelerate their studies. ### Rising Demand for Personalized Medicine The Knockout Mice Model Market is significantly influenced by the rising demand for personalized medicine. As healthcare shifts towards tailored treatments, the need for animal models that can accurately represent human genetic diversity becomes paramount. Knockout mice serve as essential tools in understanding the genetic basis of diseases, which is critical for developing personalized therapies. The market for personalized medicine is expected to grow at a compound annual growth rate (CAGR) of over 10% in the coming years, reflecting the increasing investment in research and development. This trend underscores the importance of knockout mice models in identifying patient-specific responses to therapies, thereby driving their adoption in both academic and pharmaceutical research settings. ### Growing Investment in Biomedical Research The Knockout Mice Model Market is poised for growth due to the increasing investment in biomedical research. Governments and private entities are allocating substantial funds to support research initiatives aimed at understanding genetic disorders and developing new therapies. This financial backing is crucial for the creation and maintenance of knockout mice colonies, which are essential for experimental studies. In recent years, funding for biomedical research has seen a notable increase, with billions of dollars being invested annually. This trend suggests a sustained commitment to advancing scientific knowledge, which in turn drives the demand for knockout mice models as researchers seek to explore the genetic underpinnings of diseases and test potential treatments. ### Technological Innovations in Animal Research The Knockout Mice Model Market is being propelled by technological innovations in animal research methodologies. Advances in imaging techniques, data analysis, and bioinformatics are enhancing the capabilities of researchers to utilize knockout mice models effectively. These technologies allow for more detailed phenotypic characterization and better understanding of the biological implications of gene modifications. As of 2025, the integration of artificial intelligence and machine learning in research is expected to further streamline the analysis of data derived from knockout mice studies. This evolution in research technology not only improves the efficiency of experiments but also increases the accuracy of results, thereby fostering greater reliance on knockout mice models in various fields of biomedical research. ## Future Outlook The Knockout Mice Model Market is projected to grow at a 7.32% CAGR from 2025 to 2035, driven by advancements in genetic research, increasing demand for personalized medicine, and rising investments in biotechnology. **New opportunities:** - Development of custom gene-editing services for research institutions. Expansion into emerging markets with tailored knockout models. Partnerships with pharmaceutical companies for drug discovery applications. By 2035, the market is expected to solidify its position as a cornerstone of biomedical research. ## Segment Insights ### By Application: Oncology Research (Largest) vs. Immunology Research (Fastest-Growing) The Knockout Mice Model Market exhibits a diverse distribution of applications, with oncology research holding the largest market share. This segment is bolstered by an escalating prevalence of cancer globally, driving significant investments in oncology research to develop novel therapies. Following closely are genetic and pharmaceutical research, which also contribute substantially to the market, while immunology research is emerging strongly as a critical area, reflecting a significant evolution in therapeutic approaches aimed at autoimmune and infectious diseases. Furthermore, the growth trends within the Knockout Mice Model Market are heavily influenced by advancements in [genetic engineering](https://www.marketresearchfuture.com/reports/genetic-engineering-market-1528) and biopharmaceutical technologies. As research aims to unlock complex biological pathways and mechanisms, the demand for innovative models like knockout mice is intensifying. The immunology research segment, in particular, is gaining momentum due to increased awareness of immune system disorders and ongoing clinical trials, highlighting its status as the fastest-growing domain in this market. Oncology Research: Dominant vs. Immunology Research: Emerging Oncology research is the dominant segment within the Knockout Mice Model Market, characterized by its pivotal role in cancer studies and drug discovery processes. This segment benefits from substantial public and private funding, alongside a pressing global need for effective cancer therapies. In contrast, immunology research is emerging as a noteworthy area of focus, leveraging knockout mice models to investigate the underpinnings of immune responses and the development of vaccines. The rapid evolution in immunology aligns with heightened research initiatives targeting autoimmune disorders and infectious diseases, fostering a burgeoning market landscape. As both segments continue to progress, their interdependence may lead to innovative approaches in therapeutic development and a more holistic understanding of disease mechanisms. ### By Type: Constitutive Knockout Mice (Largest) vs. Conditional Knockout Mice (Fastest-Growing) In the Knockout Mice Model Market, the distribution of market share among various types is predominant with Constitutive Knockout Mice leading the pack. This segment captures the largest share due to its extensive application in genetic research and disease modeling. In contrast, Conditional Knockout Mice, despite currently holding a smaller market share, are gaining traction rapidly as researchers increasingly adopt advanced techniques for targeted gene expression. Knockout Mice: Constitutive (Dominant) vs. Conditional (Emerging) Constitutive Knockout Mice represent a dominant segment in the market, characterized by total gene inactivation, effectively rendering the gene inactive throughout the organism's life. This established type is primarily used in studies requiring a complete loss of gene function. Meanwhile, Conditional Knockout Mice are emerging, offering flexibility through targeted gene editing that allows researchers to activate or deactivate genes in specific tissues or at specific developmental stages. As technology advances, the ability to control gene expression will likely accelerate the growth of this segment, meeting the evolving demands of the scientific community. ### By Key End User: Pharmaceutical Companies (Largest) vs. Biotechnology Companies (Fastest-Growing) The Knockout Mice Model Market exhibits a diverse distribution of market share among various key end users, with pharmaceutical companies securing the largest share due to their extensive research and development initiatives focusing on drug discovery and testing. Academic institutions closely follow, relying heavily on knockout mice for fundamental research and teaching purposes. Contract Research Organizations (CROs) play a vital enabling role, providing essential services to both pharmaceutical and biotechnology firms, thus influencing their market dynamics significantly. Academic Institutions (Dominant) vs. Contract Research Organizations (Emerging) In the Knockout Mice Model Market, academic institutions dominate by utilizing these models for pioneering research and educational purposes. Their infrastructure and funding support robust research programs, making them critical players in advancing genetic studies. On the other hand, Contract Research Organizations (CROs) represent an emerging segment that is becoming increasingly important. They offer outsourcing solutions for preclinical and clinical development, allowing pharmaceutical and biotech firms to focus on innovation. As drug development accelerates, CROs are expected to grow rapidly, providing tailored services that cater to the complex needs of their clients. ### By Technology: CRISPR-Cas9 (Largest) vs. Homologous Recombination (Fastest-Growing) In the Knockout Mice Model Market, CRISPR-Cas9 holds the largest market share, reflecting its dominance due to its efficiency and precision in gene editing. This technique has become the go-to choice for researchers and scientists, allowing for faster, more cost-effective generation of knockout models compared to traditional methods. Meanwhile, Homologous Recombination, while maintaining a smaller share, is noted for its critical role in generating precise genetic modifications, particularly for specific applications in gene therapy. Technology: CRISPR-Cas9 (Dominant) vs. Homologous Recombination (Emerging) CRISPR-Cas9 stands out as the dominant technology in the Knockout Mice Model Market due to its user-friendly nature and versatility, quickly transforming research paradigms. It allows for targeted modifications with relatively low off-target effects, making it highly favored in both academic and industrial settings. On the other hand, Homologous Recombination is emerging as a key player for specific applications that demand high precision, such as generating specific models for complex diseases. Despite being overshadowed by CRISPR-Cas9, its relevance in specialized research ensures it attracts continuous investment and research interest, positioning it for potential growth. ## Regional Market Share Analysis The Global Knockout Mice Model Market revenue is witnessing consistent growth across various regions, with North America taking a significant lead in market valuation. In 2023, North America was valued at 1.05 USD Billion and is projected to reach 2.1 USD Billion by 2032, demonstrating its majority holding in the market. Europe follows as another key player, registering a market value of 0.8 USD Billion in 2023 and advancing to 1.4 USD Billion by 2032, highlighting its important role in research and development. The APAC region, valued at 0.41 USD Billion in 2023, shows potential for growth, reaching 0.9 USD Billion by 2032, driven by increasing investments in biotechnology. South America and MEA represent smaller yet developing segments, with valuations of 0.07 USD Billion and 0.06 USD Billion in 2023, respectively, expected to grow modestly to 0.15 USD Billion each by 2032. The market faces challenges such as stringent regulations and high costs, but opportunities arise from improved research capabilities and technological advancements, enhancing overall market growth and Global Knockout Mice Model Market statistics. ## Competitive Benchmarking The competitive landscape of the Global Knockout Mice Model Market is characterized by a diverse array of players, each contributing to the advancement of genetic research and pharmaceutical development through innovative approaches. This market has seen significant growth due to the increasing demand for personalized medicine and the rising prevalence of genetic disorders. As research institutions and pharmaceutical companies strive to overcome challenges in drug development and understanding complex diseases, the need for precise and reliable animal models becomes paramount. Knockout mice, which are genetically modified to lack specific genes, serve as critical tools in this endeavor. Thus, companies involved in the production and development of knockout mice are continuously enhancing their technologies, methodologies, and service offerings, creating a dynamic competitive environment that drives innovation and collaboration across the industry.  genOway stands out in the Global Knockout Mice Model Market due to its strong focus on customized genetic models and its commitment to high-quality service. The company leverages advanced genetic engineering techniques to develop tailored knockout models that meet specific client requirements, thereby addressing unique research questions. This adaptability gives genOway a competitive advantage, as researchers are increasingly seeking models that closely mimic human diseases for more effective drug testing and therapeutic development. With a robust portfolio of knockout mice that are effectively validated for various applications, genOway enjoys a solid reputation among academic and biotech organizations. The company's emphasis on customer support, scientific expertise, and reliability further solidifies its market presence, allowing it to build long-term partnerships with clients in need of sophisticated genetic models. Charles River Laboratories holds a prominent position in the Global Knockout Mice Model Market, recognized for its comprehensive portfolio of research models and in-depth expertise in genetic engineering. The company has established a reputation for delivering high-quality knockout models that accelerate drug discovery and preclinical development. Charles River Laboratories distinguishes itself through its extensive breeding and production capabilities, ensuring a consistent supply of genetically modified mice that meet stringent quality standards. Furthermore, the company emphasizes innovation through ongoing investment in cutting-edge technology and research collaborations, enabling it to stay at the forefront of genetic research. The combination of a wide-ranging product offering and a focus on advancing genetic models makes Charles River Laboratories a key player in the knockout mice market, catering to diverse needs across the pharmaceutical and academic sectors. ## Recent News & Developments In the Global Knockout Mice Model Market, significant recent developments have been noted, particularly among leading companies like genOway, Charles River Laboratories, and Horizon Discovery. These organizations have been increasingly focusing on expanding their product portfolios and enhancing their technological capabilities to meet growing research demands. The Jackson Laboratory and Envigo have also made strides in improving the genetic engineering techniques used for creating knockout mice, which contribute to advancements in biomedical research. Additionally, Biocytogen has gained attention for its innovative models catering to specific therapeutic areas. On the merger and acquisition front, notable transactions have involved key players such as Thermo Fisher Scientific and Crown Bioscience, with activities aimed at consolidating capabilities and expanding market reach. The financial health of companies involved in this market has been bolstered by a rising demand for genetic disease modeling, significantly impacting overall market growth. This evolution reflects a dynamic landscape where collaboration, technological innovation, and strategic partnerships are paramount for driving the success of knockout mice models in various research applications. ## Report Scope | MARKET SIZE 2024 | 2.744(USD Billion) | | --- | --- | | MARKET SIZE 2025 | 2.945(USD Billion) | | MARKET SIZE 2035 | 5.969(USD Billion) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.32% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Billion | | Key Companies Profiled | Jackson Laboratory (US), Charles River Laboratories (US), Taconic Biosciences (US), Horizon Discovery (GB), GenOway (FR), Crown Bioscience (US), InVivo Biosystems (US), The Jackson Laboratory (US) | | Segments Covered | Application, Type, Key End User, Technology, Regional | | Key Market Opportunities | Advancements in gene editing technologies enhance precision in the Knockout Mice Model Market. | | Key Market Dynamics | Rising demand for personalized medicine drives innovation and competition in the Knockout Mice Model Market. | | Countries Covered | North America, Europe, APAC, South America, MEA | ## Frequently Asked Questions **Q: What is the projected market valuation of the Knockout Mice Model Market by 2035?** A: The projected market valuation for the Knockout Mice Model Market is expected to reach 5.969 USD Billion by 2035. **Q: What was the market valuation of the Knockout Mice Model Market in 2024?** A: The overall market valuation of the Knockout Mice Model Market was 2.744 USD Billion in 2024. **Q: What is the expected CAGR for the Knockout Mice Model Market during the forecast period 2025 - 2035?** A: The expected CAGR for the Knockout Mice Model Market during the forecast period 2025 - 2035 is 7.32%. **Q: Which application segment is projected to have the highest valuation by 2035?** A: The Oncology Research segment is projected to reach 1.823 USD Billion by 2035, indicating strong growth. **Q: What are the key types of knockout mice models in the market?** A: The key types include Constitutive Knockout Mice, Conditional Knockout Mice, and Transgenic Mice, with Transgenic Mice expected to reach 2.279 USD Billion by 2035. **Q: Who are the leading players in the Knockout Mice Model Market?** A: Key players in the market include Jackson Laboratory, Charles River Laboratories, and Taconic Biosciences, among others. **Q: What is the projected valuation for the Pharmaceutical Research segment by 2035?** A: The Pharmaceutical Research segment is projected to reach 1.483 USD Billion by 2035, reflecting its importance in the market. **Q: Which technology is expected to dominate the Knockout Mice Model Market by 2035?** A: The CRISPR-Cas9 technology is expected to dominate, with a projected valuation of 2.5 USD Billion by 2035. **Q: What is the expected growth for academic institutions as end users in the market?** A: Academic Institutions are projected to reach 1.845 USD Billion by 2035, indicating their significant role in the market. **Q: How does the market for Conditional Knockout Mice compare to other types by 2035?** A: The market for Conditional Knockout Mice is expected to reach 1.845 USD Billion by 2035, showing comparable growth to other types. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/knock-out-mice-model-market-32678*